Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?

Clinical Infectious Diseases

Volumn 21, Issue 4, 1995, Pages 977-980

  Stevens, Dennis L ^a,b  

^a Boise VA Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; ENDOTOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CHEMOTAXIS; DISEASE COURSE; DRUG USE; FEVER; HUMAN; MULTIPLE ORGAN FAILURE; PAIN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; DISEASE PROGRESSION; HUMAN; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TUMOR NECROSIS FACTOR;

EID: 0028864198     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/21.4.977     Document Type: Article

References (27)

1. Smith RJ, Berk SL. Necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. South Med J 1991;84:785-7.
2. Rimailho A, Riou B, Richard C, Auzepy P. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis 1987; 155:143-5.
3. Brun-Buisson CJL, Saada M, Trunet P, Rapin M, Roujeau J, Revuz J. Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs. BMJ 1985; 290:1786.
4. Pillans PI, O’Connor N. Tissue necrosis and necrotizing fasciitis after intramuscular administration of diclofenac. Ann Pharmacother 1995;29:264-6.
5. Hird B, Byme K. Gangrenous streptococcal myositis: case report. J Trauma 1994;36:589-91.
6. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992;14:2-13.
7. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1-7.
8. Simon LS, Mills JA. Nonsteroidal antiinflammatory drugs (first of two parts). N Engl J Med 1980;302:1179-85.
9. Horan TD, Noujaim AA, McPherson TA. Effect of indomethacin on human neutrophil chemiluminescencc and microbicidal activity. Immunophar-macology 1983;6:97-106.
10. Flynn PJ, Becker WK, Veroellotti GM, et al. Ibuprofen inhibits granulocyte responses to inflammatory mediators. A proposed mechanism for reduction of experimental myocardial infarct size. Inflammation 1984;8:33-44.
11. Biemond P, Swaak AJG, Penders JMA, Beindorff CM, Koster JF. Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase. Ann Rheum Dis 1986;45:249-55.
12. Solberg CO, Allred CD, Hill HR. Influence of phenylbutazone on leukocyte chemiluminescence and function. Acta Pathol Microbiol Scand [C] 1978;860:165-71.
13. Kaplan HB, Edelson HS, Korchak HM, Given WP, Abramson S, Weiss-mann G. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochemical Pharmacology 1984;33:371-8.
14. Abramson S, Edelson H, Kaplan H, Ludewig R, Weissmann G. Inhibition of neutrophil activation by nonsteroidal anti-inflammatory drugs. Am J Med 1984 (Symposium on NSAIDs).
15. Maitich GD, Danner RL, Ceska M, Suffredini AF. Detection of interleukin8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med 1991; 173:1021-4.
16. Spinas GA, Bloesch D, Keller U, Zimmerli W, Camisuli S. Pretreatment with ibuprofen augments circulating tumor necrosis factor-a, interleukin-6, and elastase during acute endotoxemia. J Infect Dis 1991; 163:89-95.
17. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988;318:1481-6.
18. Hackett SP, Stevens DL. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyro-genic exotoxin A and streptolysin O. J Infect Dis 1992; 165:879-85.
19. Hackett SP, Stevens DL. Superantigens associated with staphylococcal and streptococcal toxic shock syndromes are potent inducers of tumor necrosis factor-/? synthesis. J Infect Dis 1993;168:232-5.
20. Stevens DL, Bryant AE, Hackett SP. Gram-positive shock. Curr Opin Infect Dis 1992;5:355-63.
21. Stevens DL, Bryant AE, Hackett SP. Sepsis syndromes and toxic shock syndromes: concepts in pathogenesis and a perspective of future treatment strategies. Curr Opin Infect Dis 1993;6:374-83.
22. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972;240:410-1.
23. Kunkel S, Wiggins R, Chensue S, Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun 1986;137:404-10.
24. Jung TTK, Giebink GS, Juhn SK. Effects of ibuprofen, corticosteroid, and penicillin on the pathogenesis of experimental pneumococcal otitis media. In: Lim DJ, Bluestone CD, Klein JO, Nelson JD, eds. Recent advances in otitis media with effusion. Proceedings of the Third International Symposium. Toronto: BC Decker, 1984:269 72.
25. Roberts NJ Jr. The immunological consequences of fever. In: Mackowiak PA, ed. Fever: basic mechanisms and management. New York: Raven Press, 1991:125-42.
26. O’Reilly T, Zak O. Elevated body temperature restricts growth of Haemophilus influenzae type b during experimental meningitis. Infect Immun 1992;60:3448-51.
27. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin-1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988;81:1162-72.